Adicon Holdings Limited (09860.HK)

ADICON Holdings Ltd. engages in the provision of independent clinical laboratory services. The company is headquartered in Hangzhou, Zhejiang and currently employs 5,151 full-time employees. The company went IPO on 2023-06-30. The firm is engaged in the provision of medical testing, clinical trials, scientific research services, health management and pathology consultation services. The firm focuses on the development of core disease areas such as infectious diseases, women's health, solid tumors, perinatal & children's centers, and blood, covering many subjects such as internal medicine, pediatrics, obstetrics and gynecology, oncology, and neurology.